Laddar...
Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval
IMPORTANCE: A common justification for high cancer drug prices is the sizable research and development (R&D) outlay necessary to bring a drug to the US market. A recent estimate of R&D spending is $2.7 billion (2017 US dollars). However, this analysis lacks transparency and independent repli...
Sparad:
| I publikationen: | JAMA Intern Med |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Medical Association
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5710275/ https://ncbi.nlm.nih.gov/pubmed/28892524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2017.3601 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|